[1]杨文萍,杨 丹,唐海君,等.参桂强心汤治疗慢性心力衰竭气虚血瘀痰饮证疗效研究[J].陕西中医,2024,(12):1654-1657.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.014]
　YANG Wenping,YANG Dan,TANG Haijun,et al.The curative effect of Shengui Qiangxin decoction on patients with chronic heart failure syndrome of Qi deficiency and blood stasis and phlegm[J].,2024,(12):1654-1657.[doi:DOI:10.3969/j.issn.1000-7369.2024.12.014]
点击复制

参桂强心汤治疗慢性心力衰竭气虚血瘀痰饮证疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年12期
页码:
1654-1657
栏目:
临床研究
出版日期:
2024-12-05

文章信息/Info

Title:
The curative effect of Shengui Qiangxin decoction on patients with chronic heart failure syndrome of Qi deficiency and blood stasis and phlegm
作者:
杨文萍1; 杨 丹1; 唐海君1; 蒋 莹1; 彭 艳1; 范小春2
(1.南充市中医医院,四川 南充 637000; 2.筋骨病中医药防治南充市重点实验室,四川 南充 637000)
Author(s):
YANG Wenping; YANG Dan; TANG Haijun; JIANG Ying; PENG Yan; FAN Xiaochun
(Nanchong Hospital of Traditional Chinese Medicine,Nanchong 637000,China)
关键词:
慢性心力衰竭;  参桂强心汤;  中医证候积分;  左心室射血分数;  N末端脑钠肽前体;  6分钟步行试验
Keywords:
Chronic heart failure;  Shengui Qiangxin decoction;  Traditional Chinese medicine syndrome score;  LVEF;  NT-proBNP;  6MWT
分类号:
R 541
DOI:
DOI:10.3969/j.issn.1000-7369.2024.12.014
文献标志码:
A
摘要:
目的:研究参桂强心汤治疗慢性心力衰竭(CHF)气虚血瘀痰饮证患者疗效。方法:选取72例CHF气虚血瘀痰饮证患者,随机分成两组,对照组(n=36)采用西医标准治疗,治疗组(n=36)在对照组的基础上增加参桂强心汤加减治疗。观察比较两组患者疗效与中医证候积分、左心室射血分数(LVEF)、N末端脑钠肽前体(NT-proBNP)水平、血管内皮功能、明尼苏达心衰量表积分(MLHFQ)及6MWT。结果:治疗组治疗总有效率明显高于对照组(P<0.05)。治疗后两组中医证候积分显著下降,治疗组下降更明显(均P<0.05)。治疗后,两组LVEF与NT-proBNP水平明显改善,且治疗组LVEF更高,NT-proBNP水平更低(均P<0.05)。治疗后两组VEGF水平升高,ET-1水平降低,相较对照组,治疗组VEGF水平更高,ET-1水平更低(均P<0.05)。治疗后,两组MLHFQ积分、6MWT改善,且治疗组MLHFQ积分更低,6MWT更高(均P<0.05)。结论:参桂强心汤加减治疗CHF气虚血瘀痰饮证患者能有效改善其中医证候积分、提高中医证候疗效,改善LVEF和NT-proBNP水平、血管内皮功能、MLHFQ积分、6MWT。
Abstract:
Objective:To study the curative effect of Shengui Qiangxin decoction on patients with chronic heart failure(CHF)syndrome of Qi deficiency,blood stasis and phlegm.Methods:72 patients with CHF syndrome of Qi deficiency and blood stasis and phlegm drink were randomly divided into two groups.The control group(n=36)received conventional drug treatment,and the treatment group(n=36)received Shengui Qiangxin decoction treatment on the basis of the control group.Traditional Chinese medicine syndrome scores,therapeutic effects,left ventricular ejection fraction(LVEF),NT-proBNP level,vascular endothelial function,the Minnesota Living with Failure Questionnaire(MLHFQ)scores,and 6MWT of the two groups were compared.Results:The total effective rate of the control group was significantly lower than that of the traditional Chinese medicine group(P<0.05).After treatment,LVEF and NT-proBNP levels of the two groups were significantly improved,and LVEF level of the treatment group was higher than that of the control group,NT-proBNP level was lower than that of the control group(all P<0.05).After treatment,VEGF level increased,ET-1 level decreased,VEGF level in treatment group was higher than that in control group,ET-1 level was lower than that in control group(all P<0.05).After treatment,the MLHFQ score and 6MWT of the two groups were improved,and the MLHFQ score of the treatment group was lower than that of the control group,and the 6MWT score was higher than that of the control group(all P<0.05).Conclusion:Shengui Qiangxin decoction can effectively improve the TCM syndrome score,improve the efficacy of TCM syndrome,improve the level of LVEF,NT-proBNP and vascular endothelial function,MLHFQ score and 6MWT results in patients with CHF Qi deficiency and blood stasis syndrome.

参考文献/References:

[1] 陈金权,王蕊.右美托咪定对慢性心力衰竭大鼠的作用及机制研究[J].陕西医学杂志,2022,51(6):664-667.
[2] 龚帆影,杜玉颖,李佳,等.抗心衰方对慢性心力衰竭患者心功能及氧化应激功能的影响[J].南京中医药大学学报,2023,39(2):118-123.
[3] 倪凤扬,项羽.慢性心力衰竭患者血清半胱氨酸蛋白酶抑制剂C与血脂水平的相关性[J].中南大学学报(医学版),2023,48(1):34-39.
[4] 江洋,刘泽岩,叶丽,等.血清LncRNA FAF、ITIH4在慢性心力衰竭患者中的表达意义及对预后的预测价值[J].疑难病杂志,2024,23(4):418-422,428.
[5] 朱明军.中医药治疗慢性心力衰竭临床疗效评价与思考[J].北京中医药大学学报,2023,46(7):902-907.
[6] 王秀萍,王铭,马立旭,等.消饮化瘀方对慢性心力衰竭模型大鼠心功能及IL-1β水平的影响[J].中国老年学杂志,2023,43(18):4497-4499.
[7] 骆睿翔,张晨,庄锐,等.慢性心力衰竭伴轻度认知障碍中医证素与认知功能的相关性研究[J].世界中医药,2024,19(2):225-229.
[8] 胡笛,邬婉蓉,叶勇,等.基于“心肺同治”理论辨治慢性心力衰竭[J].陕西中医,2023,44(11):1581-1584.
[9] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122.
[10] 中华中医药学会慢性心力衰竭中医诊疗指南项目组.慢性心力衰竭中医诊疗指南(2022年)[J].中医杂志,2023,64(7):743-756.
[11] 国家食品药品监督管理局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:77-85.
[12] 李刚,陈紫凡.左西孟旦治疗老年慢性心力衰竭患者临床疗效及对患者心功能、肾素-血管紧张素-醛固酮系统的影响[J].陕西医学杂志,2020,49(10):1321-1324.
[13] 张慧,陆丽娟,成珍容,等.慢性心力衰竭患者和照护者对疾病症状的二元评价一致性现状及影响因素分析[J].中国护理管理,2024,24(3):356-361.
[14] 胡耀东,杨一波,田敏.芪苈强心胶囊对慢性心力衰竭的临床研究[J].中华中医药学刊,2024,42(5):36-40.
[15] 冯浩,马学锐,赵健.麝香通心滴丸治疗慢性心力衰竭作用机制研究进展[J].陕西中医,2024,45(3):424-426.
[16] 李苗,张妍,雷瑗琳.心脾同治在慢性心力衰竭治疗中的应用进展[J].陕西中医,2021,42(6):814-816.
[17] 张柂儇,刘海龙,王瑞琼,等.黄芪化学成分和药理作用及Q-marker预测分析[J].中国新药杂志,2023,32(4):410-419.
[18] 孙鹏,苏红,周英莲,等.黄芪桂枝五物合真武汤加减对慢性心力衰竭(阳气亏虚证)疾病进展和预后的影响[J].中国中医基础医学杂志,2019,25(4):496-500.
[19] 徐志伟,李季文,马新换,等.当归不同药用部位的化学成分及药理作用研究进展[J].中华中医药学刊,2024,42(4):74-77.
[20] 闫海峰,张泽宇,姚明鹤,等.桂枝-白芍治疗慢性心力衰竭作用机制的网络药理学分析[J].中国中医基础医学杂志,2023,29(3):464-469.
[21] 杨乐乐,林丽君,吴小芬,等.人参总皂苷调控过氧化物酶体增殖物激活受体通路治疗心力衰竭大鼠的研究[J].中国临床药理学杂志,2023,39(7):976-979.
[22] 吴昱杰,王智博,李瑛,等.慢性心力衰竭气虚血瘀证及复方人参补气颗粒干预机制的蛋白质组学研究[J].中国中药杂志,2021,46(19):5052-5063.
[23] 徐文,陈朝聪,徐文娟.复方丹参滴丸联合坎地沙坦酯片对老年慢性心力衰竭患者的临床疗效[J].中成药,2023,45(8):2797-2800.
[24] 章轶立,李园,刘俊杰,等.基于生物分子网络的黄芪-丹参药对干预慢性心力衰竭作用机制预测研究[J].中国中医药信息杂志,2020,27(2):93-98.
[25] 李孟,曾梦楠,张志广,等.北葶苈子化学成分的研究[J].中成药,2019,41(1):105-110.
[26] 邓静,颜丹娜,吴孟华,等.桃仁药性与应用的古今比较[J].中药材,2023,46(4):1034-1042.

相似文献/References:

[1]杨自生,金 琪,简立国.参苓养心汤治疗慢性心衰的疗效及对心功能、活动耐力、 NTProBNP、hsCRP的影响*[J].陕西中医,2019,(2):167.
　YANG Zisheng,JIN Qi,JIAN Liguo..The effect of Shenling Yangxin decoction on chronic heart failure and its effect on cardiac function，activity endurance，NTProBNP and hsCRP[J].,2019,(12):167.
[2]孙 哲,杨 默,石宗华.丹参多酚酸盐与丹参酮治疗慢性心力衰竭临床研究[J].陕西中医,2019,(5):591.
　SUN Zhe,YANG Mo,SHI Zonghua..Clinical effect and mechanism of salvianolate and Tanshinone in the treatment of chronic heart failure[J].,2019,(12):591.
[3]向宗兴,拓 文,仇卫峰,等.黄芪保心汤配合西药治疗慢性心力衰竭临床研究*[J].陕西中医,2019,(8):1085.
　XIANG Zongxing,TUO Wen,QIU Weifeng,et al.Clinical value of Huangqi Baoxin decoction combined with western medicine in the treatment of chronic heart failure[J].,2019,(12):1085.
[4]尚加芬.参芪附仙饮联合盐酸曲美他嗪片辨治慢性心力衰竭心肾阳虚证临床研究[J].陕西中医,2020,(1):38.
[5]陈宗伟,沈志涛,郑振国,等.芪苈强心胶囊配合保元汤加减治疗慢性心力衰竭临床研究*[J].陕西中医,2020,(2):191.
　CHEN Zongwei,SHEN Zhitao,ZHENG Zhenguo,et al.Observation on the effect of Qili Qiangxin capsules assist Baoyuan decoction in the treatment of chronic heart failure[J].,2020,(12):191.
[6]凌 望,孙思明,王璐玲,等.温阳益气活血方改善慢性心力衰竭患者生活质量临床研究*[J].陕西中医,2020,(5):621.[doi:DOI:10.3969/j.issn.10007369.2020.05.019]
　LING Wang,SUN Siming,WANG Luling,et al.A Study on the quality of life about Wenyang Yiqi Huoxue therapy in the treatment of chronic heart failure[J].,2020,(12):621.[doi:DOI:10.3969/j.issn.10007369.2020.05.019]
[7]朱 杰,林兆奋△,胡 聃,等.中西医结合治疗慢性心力衰竭研究进展*[J].陕西中医,2020,(9):1342.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.046]
[8]刘 薇,张玉焕,李 争.芪参益气滴丸对老年气虚血瘀型心力衰竭患者心肌保护、炎症状态的影响[J].陕西中医,2021,(1):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
　LIU Wei,ZHANG Yuhuan,LI Zheng.Effects of Qishen Yiqi dropping pills on myocardial protection,inflammatory state and serum cell adhesion molecule level in elderly patients with heart failure caused by qi deficiency and blood stasis[J].,2021,(12):37.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.008]
[9]黄光明.理中汤加减治疗慢性心力衰竭及对患者血清BNP、IL-10及NOS水平的影响研究[J].陕西中医,2021,(2):159.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.006]
　HUANG Guangming.Modified Lizhong decoction on clinical symptoms and levels of serum BNP,IL-10 and NOS in patients with chronic heart failure[J].,2021,(12):159.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.006]
[10]胡 芳,谭明娜,谭小娥,等.加味五苓散联合西药治疗慢性心力衰竭疗效及对患者心功能、纤维化指标、炎性因子水平的影响[J].陕西中医,2021,(2):167.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.008]
　HU Fang,TAN Mingna,TAN Xiao'e,et al.Effects of modified Wuling powder combined with western medicine on levels of cardiac function,fibrosis indicators and inflammatory factors in patients with chronic heart failure[J].,2021,(12):167.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.008]

备注/Memo

备注/Memo:
基金项目:四川省中医药管理局科研项目(2024MS614); 四川省南充市科技应用基础研究项目(23YYJCYJ0127); 医学影像四川重点实验室科研资金资助项目(MIKL202309)
更新日期/Last Update: 2024-12-05